Insider Monkey13h agobullish
Democrats Win Midterms: 5 Best Healthcare and Insurance Stocks To BuyNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool1d agoneutral
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity TrialsSimply Wall St.1d agoneutral
Hims & Hers Stock After Lilly Weight Loss Drug Deal Has The Bull Case Changed?Simply Wall St.1d agoneutral
Hims & Hers Health (HIMS) Adds FDA Approved Obesity Drugs To Its PlatformMotley Fool2d agoneutral
Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the EvidenceSimply Wall St.2d agoneutral
Eli Lilly (LLY) Highlights ACR Data, Is The Stock Still 8% Undervalued?Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementInvestorsHub2d agoneutral
Eli Lilly Partners With Hims & Hers to Expand Access to Obesity Treatments Through Telehealth